Skip to main content

Peer Review reports

From: PD-1 blockade in combination with zoledronic acid to enhance the antitumor efficacy in the breast cancer mouse model

Original Submission
19 Oct 2017 Submitted Original manuscript
26 Oct 2017 Author responded Author comments - yuan li
Resubmission - Version 2
26 Oct 2017 Submitted Manuscript version 2
15 Nov 2017 Reviewed Reviewer Report - Pei-Jen Lou
20 Nov 2017 Reviewed Reviewer Report - Alexander Beatty
27 Nov 2017 Author responded Author comments - yuan li
Resubmission - Version 3
27 Nov 2017 Submitted Manuscript version 3
9 Dec 2017 Reviewed Reviewer Report - Pei-Jen Lou
10 Dec 2017 Reviewed Reviewer Report - Alexander Beatty
22 Dec 2017 Author responded Author comments - yuan li
Resubmission - Version 4
22 Dec 2017 Submitted Manuscript version 4
26 Jan 2018 Author responded Author comments - yuan li
Resubmission - Version 5
26 Jan 2018 Submitted Manuscript version 5
Publishing
19 Apr 2018 Editorially accepted
19 Jun 2018 Article published 10.1186/s12885-018-4412-8

You can find further information about peer review here.

Back to article page